Descripción
Ranitidine Injection 50 mg/2 mL is a sterile injectable histamine H2-receptor antagonist used to reduce gastric acid secretion. It is indicated for the short-term treatment and prevention of acid-related gastrointestinal disorders in hospitalized patients or when oral therapy is not appropriate.
Active Ingredient
Ranitidine Hydrochloride equivalent to Ranitidine 50 mg/2 mL
Therapeutic Category
H2-Receptor Antagonist / Antiulcer Agent
Indications
Where approved, Ranitidine Injection is indicated for:
- Treatment of gastric ulcers
- Treatment of duodenal ulcers
- Gastroesophageal reflux disease (GERD)
- Hypersecretory conditions (e.g., Zollinger-Ellison syndrome)
- Prevention of stress ulcers in critically ill patients
- Prevention of aspiration of gastric acid before surgery
- Patients unable to take oral antiulcer medication
Benefits
- Rapid reduction of gastric acid secretion
- Helps relieve symptoms of acid-related disorders
- Supports healing of gastric and duodenal ulcers
- Injectable formulation for hospital and emergency care
- Suitable for patients unable to receive oral medication
Valoraciones
No hay valoraciones aún.